Sign in
Back
Heterogeneous Catalysis to Drive the Waste-to-Pharma Concept: From Furanics to Active Pharmaceutical Ingredients
Journal article   Open access  Peer reviewed

Heterogeneous Catalysis to Drive the Waste-to-Pharma Concept: From Furanics to Active Pharmaceutical Ingredients

Rafael Luque, Zeid A. ALOthman, Alina M. Balu and Leonid Voskressensky
Molecules (Basel, Switzerland), Vol.26(21), p.6738
08/11/2021
DOI: https://doi.org/10.3390/molecules26216738
PMCID: 8587078
PMID: 34771146

Abstract

Biochemistry & Molecular Biology Chemistry Chemistry, Multidisciplinary Life Sciences & Biomedicine Physical Sciences Science & Technology
A perspective on the use of heterogeneous catalysis to drive the waste-to-pharma concept is provided in this contribution based on the conversion of furanics to active pharmaceutical ingredients (APIs). The provided overview of the concept in this perspective article has been exemplified for two key molecule examples: Ancarolol and Furosemide.
url
https://doi.org/10.3390/molecules26216738View
Published (Version of record) Open

Metrics

1 Record Views

Details